Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
- Levis, M.
- Ravandi, F.
- Wang, E.S.
- Baer, M.R.
- Perl, A.
- Coutre, S.
- Erba, H.
- Stuart, R.K.
- Baccarani, M.
- Cripe, L.D.
- Tallman, M.S.
- Meloni, G.
- Godley, L.A.
- Langston, A.A.
- Amadori, S.
- Lewis, I.D.
- Nagler, A.
- Stone, R.
- Yee, K.
- Advani, A.
- Douer, D.
- Wiktor-Jedrzejczak, W.
- Juliusson, G.
- Litzow, M.R.
- Petersdorf, S.
- Sanz, M.
- Kantarjian, H.M.
- Sato, T.
- Tremmel, L.
- Bensen-Kennedy, D.M.
- Small, D.
- Smith, B.D.
- Montrer des auteurs +
ISSN: 1528-0020, 0006-4971
Année de publication: 2011
Volumen: 117
Número: 12
Pages: 3294-3301
Type: Article